Irsyad Khairil net worth

Who is Irsyad Khairil?

Irsyad Khairil is a co-founder of Valink Therapeutics, a company that participated in Y Combinator Winter 2021.

Highlights:

• University of California, Berkeley
• Y Combinator
• Valink Therapeutics

About Valink Therapeutics

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

FAQ: Irsyad Khairil net worth and Valink Therapeutics valuation

What is Irsyad Khairil's net worth?

Irsyad Khairil's estimated net worth is $16.52M (range $11.56M – $24.78M) as of 2026. Irsyad Khairil is Founder at Valink Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Valink Therapeutics valuation?

Valink Therapeutics's estimated valuation on Entrepreneurial Check is $118.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Irsyad Khairil's role?

Irsyad Khairil is Founder at Valink Therapeutics, a Y Combinator-backed startup (batch W21).